代谢性高血压——新的高血压类型及其面临的挑战  

Metabolic hypertension:a new and challenging form of hypertension

作　　者：祝之明[1] 

机构地区：[1]第三军医大学全军高血压代谢病中心重庆大坪医院高血压内分泌科重庆市高血压研究所,重庆400042

出　　处：《中国实用内科杂志》2011年第8期604-605,共2页Chinese Journal of Practical Internal Medicine

摘　　要：代谢异常巳成为我国高血压患病率升高的主要原因,代谢性高血压巳成为高血压的主要临床类型,其发病机制除涉及经典血压调控途径外,尚与免疫炎症关系密切。另外,血压调控器官的代谢性损害也是血压升高的重要原因。目前的高血压药物治疗对高血压合并代谢异常的控制有一定局限性,探索新的治疗策略是面临的新挑战。Metabolic disorders have become the main cause for up-going prevalence of hypertension in China. As the major form of hypertension in clinics, metabolic hypertension appears closely correlated with immunological inflammation, apart from the classical mechanism on blood pressure control. Furthermore, the increase in blood pressure can also be due to metabolic damage of target organs. Currently available medications are limited in hypertension complicated with metabolic disorders, and the exploration for novel therapeutic strategies represents a challenge.

关 键 词：代谢性高血压 代谢紊乱 免疫炎症 

分 类 号：R544.1[医药卫生—心血管疾病]